1. Home
  2. EHTH vs KYNB Comparison

EHTH vs KYNB Comparison

Compare EHTH & KYNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo eHealth Inc.

EHTH

eHealth Inc.

N/A

Current Price

$0.54

Market Cap

28.5M

Sector

Finance

ML Signal

N/A

Logo Kyntra Bio Inc. Common Stock

KYNB

Kyntra Bio Inc. Common Stock

N/A

Current Price

$4.38

Market Cap

32.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
EHTH
KYNB
Founded
1997
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
28.5M
32.8M
IPO Year
2006
2014

Fundamental Metrics

Financial Performance
Metric
EHTH
KYNB
Price
$0.54
$4.38
Analyst Decision
Hold
Buy
Analyst Count
4
5
Target Price
$1.81
★ $38.50
AVG Volume (30 Days)
★ 338.7K
22.8K
Earning Date
11-04-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
71.43
★ 9552.08
EPS
N/A
★ N/A
Revenue
★ $251,395,000.00
$6,440,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$2.87
$14.12
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 45.86
N/A
52 Week Low
$0.52
$4.36
52 Week High
$5.89
$9.66

Technical Indicators

Market Signals
Indicator
EHTH
KYNB
Relative Strength Index (RSI) 22.69 26.98
Support Level N/A N/A
Resistance Level $0.77 $7.41
Average True Range (ATR) 0.04 0.35
MACD 0.00 -0.08
Stochastic Oscillator 8.82 11.88

Price Performance

Historical Comparison
EHTH
KYNB

About EHTH eHealth Inc.

eHealth Inc is a company involved in private health insurance marketplace with a technology and service platform that provides consumer engagement, education and health insurance enrollment solutions. The company operates its business in two segments: Medicare which provides health insurance plans and lesser extent ancillary products such as dental and vision insurance and hospital indemnity plans, to medicare eligible consumers; and Employer and Individual provides individual and family health insurance, and small business health insurance plans and Individual Coverage Health Reimbursement Arrangements. It derives maximum revenue from Medicare Segment. All of the company's revenue is derived from the United States. It also has a presence in China.

About KYNB Kyntra Bio Inc. Common Stock

Kyntra Bio Inc is a biopharmaceutical company focused on the development of novel therapies in oncology and rare disease. The company's research programs target cancer and rare disease indications, including anemia associated with lower-risk myelodysplastic syndrome (LR-MDS) and metastatic castration-resistant prostate cancer (mCRPC). Itd pipeline drug candidates include Roxadustat and FG-3246.

Share on Social Networks: